---

Mark Offerhaus

Founder and CEO, Micreos, The Netherlands

Mark is proud of the technologies at Micreos. “I really think that the introduction of Staphefekt, the first endolysin for human use…represents a real game changer. Nothing makes me happier than reading all the authentic user reviews of the product online.”

Nominator comment: “Mark’s enthusiasm and drive has guided Micreos in their journey as a very small biotech company taking on big pharma to tackle the global issue of antibiotic resistance.”

www.micreos.com

---

Part of the Power List 2015

Who are the most influential medicine makers?

That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2015